Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments
Author:
Publisher
Aging and Disease
Subject
Cell Biology,Clinical Neurology,Geriatrics and Gerontology,Pathology and Forensic Medicine
Link
http://www.aginganddisease.org/fileup/2152-5250/PDF/2152-5250-2017-5-677.pdf
Reference56 articles.
1. Dumas L, Ring A, Butler J, Kalsi T, Harari D, Banerjee S. (2016). Improving outcomes for older women with gynecological malignancies. Cancer Treat Rev, 29: 50: 99-108.
2. Siegel RL, Miller KD, Jemal A (2016). Cancer statistics, 2016. CA Cancer J Clin, 66: 7-30.
3. Chan JK, Urban R, Cheung MK, Osann K, Shin JY, Husain A, et al. (2006). Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer, 95: 1314-20.
4. Wright JD, Chen L, Tergas AI, Patankar S, Burke WM, Hou JY, et al. (2015). Trends in relative survival for ovarian cancer from 1975 to 2011. Obstet Gynecol, 125: 1345-52.
5. Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M, Allemani C, et al. (2009). The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer, 45:1006-16.
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Surgical management of anastomotic leakage related to ovarian cancer surgery: a narrative review;Frontiers in Surgery;2024-09-11
2. Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial;Gynecologic Oncology;2024-08
3. Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study;BMC Cancer;2024-07-05
4. A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma;NAR Genomics and Bioinformatics;2024-07-02
5. Retrospective Multicenter Study of Elderly Patients With Platinum-Sensitive Relapsed Ovarian Cancer Treated With Trabectedin and Pegylated Liposomal Doxorubicin (Pld) in a Real- World Setting: A Geico Study;2024-04-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3